![](https://cdn.sanity.io/images/0vv8moc6/pharmacytimes/1e46271e9ce9710b400fb8fc485af9b644792543-7360x4912.jpg?fit=crop&auto=format)
The Role of Neoadjuvant Immunotherapy Advances in Resectable Stage III Melanoma
Melanoma is the fifth most common type of cancer in the United States, with an estimated 100,640 new cases and 8290 deaths in 2024.1 The majority of patients will present with localized disease, of which surgical resection is the treatment of choice and is …